Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Depreciation & Amortization (CF) (2016 - 2025)

Enanta Pharmaceuticals filings provide 14 years of Depreciation & Amortization (CF) readings, the most recent being $1.2 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 38.36% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.9 million, a 90.75% increase, with the full-year FY2025 number at $4.6 million, up 96.32% from a year prior.
  • Depreciation & Amortization (CF) hit $1.2 million in Q4 2025 for Enanta Pharmaceuticals, down from $1.3 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.3 million in Q3 2025 to a low of $479000.0 in Q3 2024.
  • Median Depreciation & Amortization (CF) over the past 5 years was $748000.0 (2021), compared with a mean of $797950.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): tumbled 34.49% in 2022 and later soared 168.06% in 2025.
  • Enanta Pharmaceuticals' Depreciation & Amortization (CF) stood at $780000.0 in 2021, then tumbled by 34.49% to $511000.0 in 2022, then rose by 25.64% to $642000.0 in 2023, then skyrocketed by 38.47% to $889000.0 in 2024, then surged by 38.36% to $1.2 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $1.2 million (Q4 2025), $1.3 million (Q3 2025), and $1.2 million (Q2 2025) per Business Quant data.